38 results on '"Wakumoto, Yoshiaki"'
Search Results
2. Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy
3. Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases
4. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
5. Supplementary Figure 4 from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
6. Supplementary Table 5 from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
7. Supplementary Figure 2B from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
8. Supplementary Table 2 from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
9. Supplementary Table 3 from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
10. Supplementary Table 4 from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
11. Supplementary Table 1 from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
12. Supplementary Figure 1A from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
13. Supplementary Figure 3A-C from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
14. Five Supplementary Tables from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
15. Four Supplementary Figures from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
16. Legends to Supplementary Figures from Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular Therapy
17. Automated renal cortical volume measurement for assessment of renal function in patients undergoing radical nephrectomy
18. Spermatic cord metastasis of gastric cancer diagnosed from right groin pain
19. MP26-07 THE EFFICACY AND LIMITATIONS OF EORTC RISK STRATIFICATION FOR THE PREDICTION OF RECURRENCE AND PROGRESSION OF 1,024 JAPANESE NON-MUSCLE INVASIVE BLADDER CANCERS
20. Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib
21. Port site hernia at the robotic arm port after robotic‐assisted laparoscopic radical prostatectomy
22. Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
23. Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up
24. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems”
25. Endurological treatment trend of upper urinary urolithiasis in Japan from the Japanese Diagnosis Procedure Combination Database
26. Movement of target organs and anatomical landmarks caused by body position change during urological laparoscopic surgery
27. Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.
28. Movement of target organs and anatomical landmarks caused by body position change during urological laparoscopic surgery.
29. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
30. Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
31. Phase II clinical study of radium-223 chloride (BAY 88-8223) in Japanese patients with symptomatic castration-resistant prostate cancer (CRPC) with bone metastases.
32. Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
33. The Advantage of a Ureteroscopic Navigation System with Magnetic Tracking in Comparison with Simulated Fluoroscopy in a Phantom Study
34. Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model
35. A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer
36. Meeting Report: the Juntendo-Catholic University Symposium in Urology 2014
37. Original paper Effect of a urinary catheter on seed position and rectal and bladder doses in CT-based post-implant dosimetry for prostate cancer brachytherapy
38. Effect of a urinary catheter on seed position and rectal and bladder doses in CT-based post-implant dosimetry for prostate cancer brachytherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.